Clinical Trial Update: Immunotherapy Vaccine and Herceptin in Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating an immunotherapy vaccine in combination with Herceptin for breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Immunotherapy Vaccine

Snippet

Sponsor: Cancer Insight, LLC | Conditions: Breastcancer | Phase 1 | Status: COMPLETED